Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 29:21:40-43.
doi: 10.1016/j.jdin.2025.05.004. eCollection 2025 Aug.

Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity

Radhika Gupta  1 , Laura Cesar  1 , Robert Micheletti  1 , Victoria Fang  1
Affiliations

Patient-reported outcomes of glucagon-like peptide-1 agonists on hidradenitis suppurativa severity

Radhika Gupta et al. JAAD Int. .
No abstract available

Keywords: GLP-1; drug response; dulaglutide; hidradenitis; liraglutide; medical dermatology; obesity; semaglutide; tirzepatide; weight loss.

PubMed Disclaimer

Conflict of interest statement

Author Gupta is a consultant for Cabaletta Bio. Dr Micheletti is a consultant for Vertex and reports research funding from Amgen, Boehringer Ingelheim, Cabaletta Bio, and InflaRx. Dr Fang is a consultant for Sonoma Biotherapeutics. Author Cesar no has conflicts of interest to declare.

References

    1. Sabat R., Jemec G.B.E., Matusiak L., Kimball A.B., Prens E., Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18. - PubMed
    1. Macklis P.C., Tyler K., Kaffenberger J., Kwatra S., Kaffenberger B.H. Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients. Arch Dermatol Res. 2022;314(3):293–300. - PubMed
    1. Chan L.J., Kaur M., Kaffenberger B.H. A case of recalcitrant hidradenitis suppurativa concomitantly treated with tirzepatide. JAAD Case Rep. 2024;52:101–102. - PMC - PubMed
    1. Jennings L., Nestor L., Molloy O., Hughes R., Moriarty B., Kirby B. The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide. Br J Dermatol. 2017;177(3):858–859. - PubMed
    1. Lyons D., Louly Nathan A., Pender E., et al. Semaglutide for weight loss in people with obesity as an adjunctive treatment for hidradenitis suppurativa: its impact on disease control and quality of life. Br J Dermatol. 2024;191(4):631–633. - PubMed

LinkOut - more resources